These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23958216)

  • 1. Management of non-melanoma skin cancer.
    Lazareth V
    Semin Oncol Nurs; 2013 Aug; 29(3):182-94. PubMed ID: 23958216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant tumors of the skin].
    Gilde K
    Orv Hetil; 2006 Dec; 147(48):2321-30. PubMed ID: 17256633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma.
    Sapijaszko M; Zloty D; Bourcier M; Poulin Y; Janiszewski P; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):249-59. PubMed ID: 25922470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raman spectroscopy differentiates squamous cell carcinoma (SCC) from normal skin following treatment with a high-powered CO2 laser.
    Fox SA; Shanblatt AA; Beckman H; Strasswimmer J; Terentis AC
    Lasers Surg Med; 2014 Dec; 46(10):757-72. PubMed ID: 25345858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for nonmelanoma skin cancer: does it have a future?
    Urosevic M; Dummer R
    Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of nonmelanoma skin cancer in 2007.
    Neville JA; Welch E; Leffell DJ
    Nat Clin Pract Oncol; 2007 Aug; 4(8):462-9. PubMed ID: 17657251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical indications for the management of non-melanoma skin cancer patients.
    DI Stefani A; Del Regno L; Piccerillo A; Peris K
    G Ital Dermatol Venereol; 2017 Jun; 152(3):286-294. PubMed ID: 28195452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of non melanoma skin cancer by the general practitioner].
    Lam Hoai X; Trakatelli M; Ahbib S; Richert B
    Rev Med Brux; 2016; 37(4):212-220. PubMed ID: 28525218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines.
    Guenther LC; Barber K; Searles GE; Lynde CW; Janiszewski P; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):205-15. PubMed ID: 26016676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Bahner JD; Bordeaux JS
    Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-melanoma skin cancer of the auricle is treated according to national guidelines.
    Gustaitytė-Larsen D; Illum P
    Dan Med J; 2013 Mar; 60(3):A4587. PubMed ID: 23484609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma.
    Zloty D; Guenther LC; Sapijaszko M; Barber K; Claveau J; Adamek T; Ashkenas J;
    J Cutan Med Surg; 2015; 19(3):239-48. PubMed ID: 25986316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical and systemic medical treatments of basal cell carcinoma.
    Sollena P; Del Regno L; Fargnoli MC; Peris K
    G Ital Dermatol Venereol; 2015 Aug; 150(4):429-34. PubMed ID: 26086413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician.
    Martinez JC; Otley CC
    Mayo Clin Proc; 2001 Dec; 76(12):1253-65. PubMed ID: 11761506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.
    Cocoş R; Schipor S; Nicolae I; Thomescu C; Raicu F
    Arch Dermatol Res; 2012 Jul; 304(5):335-42. PubMed ID: 22159575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
    Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
    Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
    Blixt E; Nelsen D; Stratman E
    Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
    Zaravinos A; Kanellou P; Spandidos DA
    Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of non-melanoma skin cancer of the head and neck.
    Lang PG; Hochman M
    J S C Med Assoc; 1994 Oct; 90(10):455-73. PubMed ID: 7990418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.